HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of uterine leiomyomas and hirsutism with nafarelin.

Abstract
Nafarelin treatment reduces both uterine and myoma volume, induces amenorrhea and improves blood indices in women with uterine leiomyomas. The gonadotropin releasing hormone analog is also effective in decreasing hair growth in women with hirsutism that is associated with excess ovarian androgen production.
AuthorsS E Monroe, J Andreyko
JournalThe Journal of reproductive medicine (J Reprod Med) Vol. 34 Issue 12 Suppl Pg. 1029-33 (Dec 1989) ISSN: 0024-7758 [Print] United States
PMID2533618 (Publication Type: Journal Article)
Chemical References
  • Nafarelin
  • Gonadotropin-Releasing Hormone
Topics
  • Female
  • Gonadotropin-Releasing Hormone (analogs & derivatives, therapeutic use)
  • Hirsutism (drug therapy)
  • Humans
  • Leiomyoma (drug therapy)
  • Nafarelin
  • Uterine Neoplasms (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: